European Journal Of Haematology

Wiley

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

European Journal Of Haematology is a journal published by Wiley in United Kingdom. It is listed in MEDLINE and PUBMED according to the sources read. Declared publication charge: 4,220 USD. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Wiley
ISSN
0902-4441 · 1600-0609
Country
United Kingdom
Access
Not open access / not declared
Declared publication charge
4,220 USD
Declared peer-review model
peer_review

Index listings

  • MEDLINE · 1987-01-01
  • PUBMED · 2009-12-01
Indexing
MEDLINE · PUBMED
APC
4,220 USD
Declared review time (DOAJ)
—
Actual review time (measured)
56 days received→accepted — computed from PubMed (n=100)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

7628

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

120

i10-index

3741

From OpenAlex open data (CC0).

Editorial & policy5
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
88%
ORCID iDs in current deposits
83%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
Identity & continuity3
Alternate titles
Haematology
Source type
journal
NLM unique ID (PubMed)
8703985
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Lymphoma Diagnosis and Treatment
  • Acute Myeloid Leukemia Research
  • Acute Myeloid Leukemia Research
  • Acute Myeloid Leukemia Research
  • Chronic Lymphocytic Leukemia Research
  • Hematopoietic Stem Cell Transplantation
  • Lymphoma Diagnosis and Treatment
  • Lymphoma Diagnosis and Treatment
Show all subjects (75)
  • Platelet Disorders and Treatments
  • Chronic Lymphocytic Leukemia Research
  • Chronic Lymphocytic Leukemia Research
  • Multiple Myeloma Research and Treatments
  • Multiple Myeloma Research and Treatments
  • Multiple Myeloma Research and Treatments
  • Hemoglobinopathies and Related Disorders
  • Hemoglobinopathies and Related Disorders
  • Hematopoietic Stem Cell Transplantation
  • Hematopoietic Stem Cell Transplantation
  • Hemoglobinopathies and Related Disorders
  • Platelet Disorders and Treatments
  • Platelet Disorders and Treatments
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Hematological disorders and diagnostics
  • Retinoids in leukemia and cellular processes
  • Acute Lymphoblastic Leukemia research
  • Acute Lymphoblastic Leukemia research
  • Chronic Myeloid Leukemia Treatments
  • Chronic Myeloid Leukemia Treatments
  • Acute Lymphoblastic Leukemia research
  • Blood groups and transfusion
  • Blood groups and transfusion
  • Iron Metabolism and Disorders
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Blood groups and transfusion
  • Neutropenia and Cancer Infections
  • Viral-associated cancers and disorders
  • Iron Metabolism and Disorders
  • Iron Metabolism and Disorders
  • Blood Coagulation and Thrombosis Mechanisms
  • Chronic Myeloid Leukemia Treatments
  • Immune Cell Function and Interaction
  • Immune Cell Function and Interaction
  • Hemophilia Treatment and Research
  • Blood disorders and treatments
  • Blood transfusion and management
  • Complement system in diseases
  • Erythrocyte Function and Pathophysiology
  • Erythrocyte Function and Pathophysiology
  • Neutropenia and Cancer Infections
  • Neutropenia and Cancer Infections
  • Eosinophilic Disorders and Syndromes
  • Viral-associated cancers and disorders
  • Eosinophilic Disorders and Syndromes
  • Viral-associated cancers and disorders
  • Blood disorders and treatments
  • Blood disorders and treatments
  • Immunodeficiency and Autoimmune Disorders
  • Immunodeficiency and Autoimmune Disorders
  • Immunodeficiency and Autoimmune Disorders
  • CNS Lymphoma Diagnosis and Treatment
  • Bone health and treatments
  • CNS Lymphoma Diagnosis and Treatment
  • Hemophilia Treatment and Research
  • Hemophilia Treatment and Research
  • Erythropoietin and Anemia Treatment
  • CNS Lymphoma Diagnosis and Treatment
  • Cancer Treatment and Pharmacology
  • Cancer Treatment and Pharmacology
  • CAR-T cell therapy research
  • Complement system in diseases
  • CAR-T cell therapy research
  • Complement system in diseases
  • Blood properties and coagulation
  • Blood properties and coagulation

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: